| __timestamp | Johnson & Johnson | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 22746000000 | 2395000 |
| Thursday, January 1, 2015 | 21536000000 | 9057000 |
| Friday, January 1, 2016 | 21685000000 | 393000 |
| Sunday, January 1, 2017 | 25354000000 | 79309000 |
| Monday, January 1, 2018 | 27091000000 | 134428000 |
| Tuesday, January 1, 2019 | 27556000000 | 175431000 |
| Wednesday, January 1, 2020 | 28427000000 | 124165000 |
| Friday, January 1, 2021 | 23402000000 | 121875000 |
| Saturday, January 1, 2022 | 24596000000 | 10114000 |
| Sunday, January 1, 2023 | 26553000000 | 9206000 |
| Monday, January 1, 2024 | 27471000000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding cost structures is crucial. Johnson & Johnson, a stalwart in the industry, has consistently maintained a robust cost of revenue, averaging around $24.9 billion annually from 2014 to 2023. This reflects a steady growth trajectory, peaking in 2020 with a 28% increase from 2014. In contrast, Wave Life Sciences Ltd., a burgeoning biotech firm, showcases a different narrative. Despite its smaller scale, the company has seen a dramatic rise in its cost of revenue, surging by over 7,000% from 2014 to 2019, before stabilizing. This stark contrast highlights the diverse financial strategies and growth phases of established giants versus emerging innovators. As the industry continues to evolve, these insights offer a glimpse into the financial dynamics shaping the future of healthcare.
Cost of Revenue: Key Insights for Johnson & Johnson and Vertex Pharmaceuticals Incorporated
Analyzing Cost of Revenue: Johnson & Johnson and BeiGene, Ltd.
Cost of Revenue Comparison: Johnson & Johnson vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Johnson & Johnson vs Ligand Pharmaceuticals Incorporated
Cost Insights: Breaking Down Johnson & Johnson and Geron Corporation's Expenses
Bristol-Myers Squibb Company vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Zoetis Inc. vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Intra-Cellular Therapies, Inc. vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Mesoblast Limited vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: Agios Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: Geron Corporation and Wave Life Sciences Ltd.